Multiple endocrine neoplasia type 2

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

For patient information, click here.

Multiple endocrine neoplasia type 2 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 2 from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Multiple endocrine neoplasia type 2 On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 2

CDC on Multiple endocrine neoplasia type 2

Multiple endocrine neoplasia type 2 in the news

Blogs on Multiple endocrine neoplasia type 2

Directions to Hospitals Treating Multiple endocrine neoplasia type 2

Risk calculators and risk factors for Multiple endocrine neoplasia type 2

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Synonyms and keywords: Familial endocrine adenomatosis type 2; Familial endocrine adenomatosis type 2a; Familial endocrine adenomatosis type 2b; Familial chromaffinomatosis type 2; Familial medullary thyroid carcinoma; Multiple endocrine adenomatosis type 2; Multiple endocrine adenomatosis type 2a; Multiple endocrine adenomatosis type 2b; Multiple endocrine neoplasia syndrome type 2; Multiple endocrine neoplasia syndrome type 2a; Multiple endocrine neoplasia syndrome type 2b; MEN type 2; MEN type 2a; MEN type 2b; MEN 2 syndrome; MEN type II; MEN type IIa; MEN type IIb; MEA type 2; MEA type 2a; MEA type 2b; Multiple endocrine neoplasms type 2; Multiple endocrine neoplasms type 2a; Multiple endocrine neoplasms type 2b; Multiple neuroma syndrome type 2; Multiple neuroma syndrome type 2a; Multiple neuroma syndrome type 2b; PTC syndrome; Sipple's syndrome; Pheochromocytoma and amyloid producing medullary thyroid carcinoma; Wagenmann-Froboese syndrome

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 2 from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria | History & Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

See also

​​​


Template:WikiDoc Sources